Optimization of pharmacotherapy of COPD patients using EURO FORTA and STOPP/START criteria

Relevance. Polypharmacy in taking medicines as one of the main consequences of comorbid pathology is a well-known risk factor for adverse drug reactions (ADRs). ADRs are often the cause of worsening disease course, disability, and mortality, especially in the elderly. This trend necessitates optimization of pharmacotherapy used in elderly patients using analytical algorithms for safety assessment. Objective. To analyze the safety of antibacterial and bronchodilator pharmacotherapy in COPD patients over 65 years old by means of comparative analysis of the data obtained according to EURO FORTA system methods and STOPP/START criteria. Methods. To conduct the study, a patient portrait was made on the basis of inpatient records data with the determination of Charlson and ADO indices. The influence of the severity of COPD course and comorbid pathology on polypharmacy was determined using the Spearman correlation coefficient (r). Evaluation of efficiency in the application of EURO FORTA and STOPP/START analytical criteria was carried out using a comparative analysis method. Statistical processing of the obtained data was performed using the StatPlus 7.0 program. Results. 113 inpatient records of elderly patients with moderately severe and severe COPD were studied. On the background of high severity of comorbid pathology, polypharmacy was observed in 102 patients (90.2%). The application of EURO FORTA and STOPP/START analytical tools in the analysis of bronchodilator and antibacterial therapy revealed 71 prescriptions of potentially unrecommended drugs in 61 (53,9%) patients. Conclusion. The analysis showed a high rate of prescribing drugs with significant risk in elderly patients. The conducted comparative analysis of two analytical tools for evaluation of the used pharmacotherapy EURO FORTA and STOPP/START demonstrated the necessity of their joint use to achieve the best results in ensuring safety of treatment of elderly patients, as they successfully complement each other.

1. Steg PG, Goldberg RJ, Gore JM, et al. Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Am J Cardiol. 2002 Aug 15;90(4):358-63. doi: 10.1016/s0002-9149(02)02489-x.

2. Сердечно-сосудистые средства в гериатрии /С. К. Зырянов, Е. А. Ушкалова, О. И. Бутранова. — Москва: ГЭОТАР-Медиа, 2023. — 224 с. [Serdechno-sosudistye sredstva. Zyryanov SK, Ushkalova EA, Butranova OI. Moscow: GEOTAR-Media, 2023. (In Russ.)]. doi: 10.33029/9704-7527-0-SER-2023-1-224.

3. Davies EA, O'Mahony MS. Adverse drug reactions in special populations — the elderly. Br J Clin Pharmacol. 2015 Oct;80(4):796-807. doi: 10.1111/bcp.12596.

4. Garfinkel D, Ilhan B, Bahat G. Routine deprescribing of chronic medications to combat polypharmacy. Ther Adv Drug Saf. 2015;6(6):212-33. doi: 10.1177/2042098615613984.

5. Bahat G, Ilhan B, Erdogan T, et al. International Validation of the Turkish Inappropriate Medication Use in the Elderly (TIME) Criteria Set: A Delphi Panel Study. Drugs Aging. 2021 Jun;38(6):513-521. doi: 10.1007/s40266-021-00855-5.

6. Кирилочев О.О., Тарханов В.С. Оценка риска осложнений лекарственной терапии геронтологических пациентов с психическими заболеваниями. Современные проблемы науки и образования. 2020;(3):106. [Kirilochev OO, Tarkhanov VS. The adverse drug reaction risk assessment of pharmacotherapy complications in elderly patients with mental disorders. Sovremennye problemy nauki i obrazovaniya. 2020;(3):106. (In Russ.)] doi:10.17513/spno.29810.

7. Motter FR, Fritzen JS, Hilmer SN, et al. Potentially inappropriate medication in the elderly: a systematic review of validated explicit criteria. Eur J Clin Pharmacol. 2018 Jun;74(6):679-700. doi: 10.1007/s00228-018-2446-0.

8. Monteiro L, Baptista S, Ribeiro-Vaz I, et al. Translation and cultural adaptation of MedStopper® — A web-based decision aid for deprescribing in older adults: A protocol. PLoS One. 2023 Apr 20;18(4):e0284464. doi: 10.1371/journal. pone.0284464.

9. O'Mahony D, O'Sullivan D, Byrne S, O'Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015 Mar;44(2):213-8. doi: 10.1093/ageing/afu145. Epub 2014 Oct 16. Erratum in: Age Ageing. 2018 May 1;47(3):489.

10. Pazan F, Weiss C, Wehling M; FORTA. The FORTA (Fit fOR The Aged) List 2021: Fourth Version of a Validated Clinical Aid for Improved Pharmacotherapy in Older Adults. Drugs Aging. 2022 Mar;39(3):245-247. doi: 10.1007/s40266-022-00922-5. Epub 2022 Feb 23. Erratum in: Drugs Aging. 2022 Jun;39(6):485.

11. Soraci L, Cherubini A, Paoletti L, et al. Safety and Tolerability of Antimicrobial Agents in the Older Patient. Drugs Aging. 2023 Jun;40(6):499-526. doi: 10.1007/s40266-023-01019-3.

12. Остроумова О.Д., Голобородова И.В. Лекарственно-индуцированное удлинение интервала QT: распространенность, факторы риска, лечение и профилактика. Consilium Medicum. 2019;21(5):62-67. [Ostroumova OD, Goloborodova IV. Drug-induced long QT interval: prevalence, risk factors, treatment and prevention. Consilium Medicum. 2019;21(5):62-67. (In Russ.)] doi: 10.26442/20751753.2019.5.190415.

13. Li X, Zoller M, Fuhr U, et al. Ciprofloxacin in critically ill subjects: considering hepatic function, age and sex to choose the optimal dose. J Antimicrob Chemother. 2019 Mar 1;74(3):682-690. doi: 10.1093/jac/dky485.

14. Ушкалова Е.А., Зырянов С.К. Левофлоксацин: соотношение "пользариск". Фарматека. 2017;S2-17:36-42. [Ushkalova EA, Zyryanov SK. Levofloxacin: benefit-risk ratio. Farmateka. 2017;S2-17:36-42. (In Russ.)].

15. Liu HH. Safety profile of the fluoroquinolones: focus on levofloxacin. Drug Saf. 2010 May 1;33(5):353-69. doi: 10.2165/11536360-000000000-00000.

16. Чучалин А.Г., Авдеев С.Н., Айсанов З.Р., Белевский А.С., Лещенко И.В., Овчаренко С.И., Шмелев Е.И. Хроническая обструктивная болезнь легких: федеральные клинические рекомендации по диагностике и лечению. Пульмонология. 2022;32(3):356-392. [Chuchalin AG, Avdeev SN, Aisanov ZR, et al. Federal guidelines on diagnosis and treatment of chronic obstructive pulmonary disease. Pulmonologiya. 2022;32(3):356-392. (In Russ.)] doi: 10.18093/0869-0189-2022-32-3-356-392.

17. Сычев Д.А., Отделёнов В.А., Краснова Н.М., Ильина Е.С. Полипрагмазия: взгляд клинического фармаколога. Терапевтический архив. 2016;88(12):94‑102. [Sychev DA, Otdelеnov VA, Krasnova NM, Il'ina ES. Polypragmasy: A clinical pharmacologist’s view. Terapevticheskii Arkhiv. 2016;88(12):94‑102. (In Russ.)]. doi 10.17116/terarkh2016881294-102.

18. Pazan F, Breunig H, Weiss C, et al. Higher FORTA (Fit fOR The Aged) scores are associated with poor functional outcomes, dementia, and mortality in older people. Eur J Clin Pharmacol. 2022 Nov;78(11):1851-1859. doi: 10.1007/s00228-022-03389-w.

19. Тарловская Е.И., Омарова Ю.В. Анализ соответствия назначенной терапии системе EURO FORTA у полиморбидных пациентов пожилого и старческого возраста с хронической сердечной недостаточностью. Кардиология. 2021;61(11):57-64. [Tarlovskaya EI, Omarova YuV. Analysis of the compliance of the prescribed therapy with the EURO FORTA system in polymorbidic patients of elderly and old age with CHF. Kardiologiia. 2021;61(11):57-64. (In Russ.)]. doi: 10.18087/cardio.2021.11.n1619

20. Lucchetti G, Lucchetti AL. Inappropriate prescribing in older persons: A systematic review of medications available in different criteria. Arch Gerontol Geriatr. 2017 Jan-Feb;68:55-61. doi: 10.1016/j.archger.2016.09.003.

21. Краснова Н.М., Сычёв Д.А., Венгеровский А.И., Александрова Т.Н. Современные методы оптимизации фармакотерапии у пожилых пациентов в условиях многопрофильного стационара. Клин. мед. 2017;95(11):1042-1049. [Krasnova NM, Sychev DA, Vengerovskii AI, Aleksandrova TN. Current methods of optimization of pharmacotherapy in elderly patients in multidisciplinary hospital. Klin. med. 2017;95 (11):1042-1049. (In Russ.)]. doi: 10.18821/0023-2149-2017-95-11-1042-1049

22. Аль-Раджави А., Зырянов С.К., Ушкалова Е.А., и др. Распространённость назначений потенциально не рекомендованных лекарственных средств в практике ведения пациентов пожилого и старческого возраста. Качественная Клиническая Практика. 2019;(1):65-73. [Al-Rajavi A, Zyryanov SK, Ushkalova EA, et al. Prevalence of potentially inappropriate medications among elderly patients in clinical practice. Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice. 2019;(1):65-73. (In Russ.)] doi: 10.24411/2588-0519-2019-10064.

23. Ma Z, Tong Y, Zhang C, Liu L. Potentially inappropriate medications and potentially prescribing omissions in Chinese older patients: Comparison of two versions of STOPP/START. J Clin Pharm Ther. 2020 Dec;45(6):1405-1413. doi: 10.1111/jcpt.13237.

24. Kara Ö, Arık G, Kızılarslanoglu MC, et al. Potentially inappropriate prescribing according to the STOPP/START criteria for older adults. Aging Clin Exp Res. 2016 Aug;28(4):761-8. doi: 10.1007/s40520-015-0475-4.

25. Гериатрическая пульмонология : руководство для врачей /под ред. Е. С. Лаптевой, А. Л. Арьева. — Москва : ГЭОТАР-Медиа, 2022. — 160 с. [Geriatricheskaya pul'monologiya: Rukovodstvo dlya vrachei. Ed by Lapteva ES, Ar'ev AL, Moscow: GEOTAR-Media, 2022. (In Russ.)]. doi: 10.33029/9704-6488-5-LAG-2022-1-160.

26. Батюкина С.В., Остроумова О.Д., Кочетков А.И., и др. Аспекты практического применения критериев STOPP/START у пациентов старшей возрастной группы с фибрилляцией предсердий и хронической болезнью почек в терапевтическом отделении многопрофильного стационара. Медицинский алфавит. 2021;(1):57-65. [Batyukina SV, Ostroumova OD, Kochetkov AI, et al. Aspects of practical application of ‘STOPP/START’ criteria in elderly patients with atrial fibrillation and chronic kidney disease in therapeutic department of multi-speciality hospital. Medical alphabet. 2021;(1):57-65. (In Russ.)]. doi: 10.33667/2078-5631-2021-1-57-65.

27. Кочетков А.И., Де В.А., Воеводина Н.Ю., и др. Анализ соответствия назначений лекарственных средств «stopp/start» критериям у пациентов пожилого и старческого возраста с сахарным диабетом 2 типа в эндокринологическом отделении многопрофильного стационара. Российский журнал гериатрической медицины. 2020;(1):47-56. [Kochetkov AI, De VA, Voevodina NYu, et al. Analysis of drug prescription appropriateness according to the STOPP/START criteria of the elderly patients with type 2 diabetes mellitus in the endocrinology department of a multi-speciality hospital. Russian Journal of Geriatric Medicine. 2020;(1):47-56. (In Russ.)] DOI: 10.37586/2686-8636-1-2020-47-56

28. Де В.А., Кочетков А.И., Черняева М.С. и др. Применение STOPP/START-критериев у пациентов пожилого и старческого возраста с фибрилляцией предсердий и ишемической болезнью сердца в отделении многопрофильного стационара. Эффективная фармакотерапия. 2023;19(5):32-42. [De VA, Kochetkov AI, Chernyaeva MS, et al. Primenenie STOPP/START-kriteriev u patsientov pozhilogo i starcheskogo vozrasta s fibrillyatsiei predserdii i ishemicheskoi bolezn'yu serdtsa v otdelenii mnogoprofil'nogo statsionara. Effektivnaya farmakoterapiya. 2023;19(5):32-42. (In Russ.)]. doi: 10.33978/2307-3586-2023-19-5-32-42.